In 2011, J. David Boyle II earned $316.82K in total compensation at Sarepta Therapeutics, Inc., primarily from $203.32K salary. Led Sarepta Therapeutics, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for J. David Boyle II, including salary, bonuses, and stock awards.
Year
2011
Total Compensation
$316.82K
Salary
$203.32K
Bonus
$0.00
Other
$113.51K
Salary
$203.32KBoard Justification
The compensation committee aims to attract and retain qualified executives while aligning their interests with those of shareholders through competitive compensation packages.
Bonus
$0.00Board Justification
Mr. Boyle was ineligible for a performance-based bonus for 2011 due to his departure from the company on July 24, 2011.
Other Compensation
$113.51KBoard Justification
The other compensation includes a lump sum cash payment of $113,507 related to severance costs upon termination.
Restricted Stock
Board Justification
No stock awards were vested in 2011 as Mr. Boyle was not employed for the full year and did not receive any stock grants that vested in 2011.
Performance Metrics
Mr. Boyle was ineligible for performance bonuses due to his departure from the company.
J. David Boyle II
Ex-CEO of Sarepta Therapeutics, Inc.
Education
Bachelor of Arts from Catholic University
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
September 3, 1954 - 71 years ago
CEO of Sarepta Therapeutics, Inc. for
1 year 3 months (Apr 2010 - Jul 2011)
Previous Experience
Senior Vice President and Chief Financial Officer at AVI BioPharma, Inc.
Holdings
Track J. David Boyle II's stock holdings and portfolio value over time.
Insider Trading
J. David Boyle II's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare J. David Boyle II with competitor CEOs and industry peers.